Works matching IS 02694727 AND DT 2014 AND VI 39 AND IP 5

Results: 25

Involvement of neuronal β<sub>2</sub> subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: Implications for pharmacotherapies.

Published in:

2014

By:

Simmons, Steven J.;
Gould, Thomas J.

Publication type:

Journal Article

A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial)

Published in:

2014

By:

Stewart, K.;
George, J.;
Mc Namara, K. P.;
Jackson, S. L.;
Peterson, G. M.;
Bereznicki, L. R.;
Gee, P. R.;
Hughes, J. D.;
Bailey, M. J.;
Hsueh, Ys. A.;
McDowell, J. M.;
Bortoletto, D. A.;
Lau, R.

Publication type:

Journal Article

Treatment of gout in a renal transplant patient leading to severe thrombocytopenia.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 571, doi. 10.1111/jcpt.12190

By:

Weiler, S.;
Aellig, N.;
Fauchère, I.;
Jetter, A.;
Corti, N.

Publication type:

Article

Biomedical journals lack a consistent method to detect outcome reporting bias: a cross-sectional analysis.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 501, doi. 10.1111/jcpt.12172

By:

Huan, L. N.;
Tejani, A. M.;
Egan, G.

Publication type:

Article

Development of multiplex pyrosequencing for HLA-B*57:01 screening using single nucleotide polymorphism haplotype.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 545, doi. 10.1111/jcpt.12175

By:

Sankuntaw, N.;
Chantarangsu, S.;
Chantratita, W.;
Sungkanuparph, S.;
Kiertiburanakul, S.;
Lulitanond, V.

Publication type:

Article

Gene polymorphism and frequencies of the NPC1L1 Gene (rs2072183, rs217434 and rs217428) in Japanese patients with dyslipidemia.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 551, doi. 10.1111/jcpt.12176

By:

Kashiwabara, Y.;
Kobayashi, Y.;
Koba, S.;
Kohyama, N.;
Ohbayashi, M.;
Murayama, J ‐ I.;
Hirano, T.;
Yamamoto, T.

Publication type:

Article

Pharmacist review prevents evolving metformin-associated lactic acidosis.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 567, doi. 10.1111/jcpt.12187

By:

Naunton, M.;
Kyle, G.;
Owoka, F.;
Naunton ‐ Boom, K.

Publication type:

Article

Involvement of neuronal β<sub>2</sub> subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: Implications for pharmacotherapies.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 457, doi. 10.1111/jcpt.12171

By:

Simmons, Steven J.;
Gould, Thomas J.

Publication type:

Article

Psychopathy: clinical features, developmental basis and therapeutic challenges.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 485, doi. 10.1111/jcpt.12182

By:

Thompson, D. F.;
Ramos, C. L.;
Willett, J. K.

Publication type:

Article

A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 consecutive patients.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 521, doi. 10.1111/jcpt.12183

By:

Bai, N.;
Chen, Y. ‐ Z.;
Fu, Y. ‐ J.;
Wu, P.;
Zhang, W. ‐ N.

Publication type:

Article

Is a flavonoid-rich diet with steamer cooking safe during calcineurin inhibitors therapy?

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 471, doi. 10.1111/jcpt.12186

By:

Peluso, I.;
Palmery, M.

Publication type:

Article

Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 564, doi. 10.1111/jcpt.12179

By:

Chagas, M. H. N.;
Eckeli, A. L.;
Zuardi, A. W.;
Pena ‐ Pereira, M. A.;
Sobreira ‐ Neto, M. A.;
Sobreira, E. T.;
Camilo, M. R.;
Bergamaschi, M. M.;
Schenck, C. H.;
Hallak, J. E. C.;
Tumas, V.;
Crippa, J. A. S.

Publication type:

Article

Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 496, doi. 10.1111/jcpt.12170

By:

Enderby, C. Y.;
Soukup, M.;
Al Omari, M.;
Zeiger, T.;
Burger, C.

Publication type:

Article

A cross-sectional survey of antimicrobial stewardship strategies in UK hospitals.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 516, doi. 10.1111/jcpt.12181

By:

Tonna, A. P.;
Gould, I. M.;
Stewart, D.

Publication type:

Article

'Selective' COX-1 or COX-2 NSAIDs: time to change a misleading measure.

Published in:

2014

By:

Raffa, R. B.;
Gudin, J. A.;
Nalamachu, S.;
Pergolizzi, J. V.

Publication type:

Editorial

Variables influencing patient satisfaction for hypnotics: difference between zolpidem and brotizolam.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 507, doi. 10.1111/jcpt.12174

By:

Hosono, T.;
Homma, M.;
Satoh, M.;
Kohda, Y.

Publication type:

Article

A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial).

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 527, doi. 10.1111/jcpt.12185

By:

Stewart, K.;
George, J.;
Mc Namara, K. P.;
Jackson, S. L.;
Peterson, G. M.;
Bereznicki, L. R.;
Gee, P. R.;
Hughes, J. D.;
Bailey, M. J.;
Hsueh, YS. A.;
McDowell, J. M.;
Bortoletto, D. A.;
Lau, R.

Publication type:

Article

Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 511, doi. 10.1111/jcpt.12178

By:

Pasina, L.;
Djade, C. D.;
Tettamanti, M.;
Franchi, C.;
Salerno, F.;
Corrao, S.;
Marengoni, A.;
Marcucci, M.;
Mannucci, P. M.;
Nobili, A.

Publication type:

Article

The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 555, doi. 10.1111/jcpt.12189

By:

Hopkins, A. M.;
O'Doherty, C. E.;
Foster, D. J. R.;
Suppiah, V.;
Upton, R. N.;
Spargo, L. D.;
Cleland, L. G.;
Proudman, S. M.;
Wiese, M. D.

Publication type:

Article

A pharmacokinetic drug interaction study between nebivolol and paroxetine in healthy volunteers.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 535, doi. 10.1111/jcpt.12180

By:

Briciu, C.;
Neag, M.;
Muntean, D.;
Vlase, L.;
Bocsan, C.;
Buzoianu, A.;
Gheldiu, A. ‐ M.;
Achim, M.;
Popa, A.

Publication type:

Article

A case of synthetic oestrogen-induced autoimmune hepatitis with microvesicular steatosis.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 573, doi. 10.1111/jcpt.12191

By:

Morii, K.;
Nishisaka, M.;
Nakamura, S.;
Oda, T.;
Aoyama, Y.;
Yamamoto, T.;
Kishida, H.;
Okushin, H.;
Uesaka, K.

Publication type:

Article

Astragalus membranaceus as a cause of increased CA19-9 and liver and kidney cysts: a case report.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 561, doi. 10.1111/jcpt.12173

By:

Tong, X.;
Xiao, D.;
Yao, F.;
Huang, T.

Publication type:

Article

Reliability of self-reporting of antibiotic consumption in the community - Index of Reliability.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 468, doi. 10.1111/jcpt.12184

By:

Ferson, K.;
Montgomery, J.;
Moore, R. E.;
Millar, B. C.;
Leggett, P.;
Coulter, W. A.;
Goldsmith, C. E.;
Moore, J. E.

Publication type:

Article

Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 475, doi. 10.1111/jcpt.12177

By:

Walter, C. P.;
Bleske, B. E.;
Dorsch, M. P.

Publication type:

Article

Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancy.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 541, doi. 10.1111/jcpt.12188

By:

Horst, P. G. J.;
Larmené ‐ Beld, K. H. M.;
Bosman, J.;
Veen, E. L.;
Wieringa, A.;
Smit, J. P.

Publication type:

Article